Systematic review and meta-analysis of lactose digestion, its impact on intolerance and nutritional effects of dairy food restriction in inflammatory bowel diseases

Nutrition Journal

Volumn 15, Issue 1, 2016, Pages

  Szilagyi, Andrew ^a   Galiatsatos, Polymnia ^a   Xue, Xiaoqing ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Inflammatory Bowel Diseases; Intolerance; Lactose malabsorption

Indexed keywords

ARTICLE; BREATH ANALYSIS; CROHN DISEASE; DAIRY PRODUCT; DIET RESTRICTION; DIGESTION; DISEASE ASSOCIATION; DISEASE COURSE; ETHNICITY; FOOD INTAKE; GENOTYPE; HUMAN; INFLAMMATORY BOWEL DISEASE; JEJUNUM BIOPSY; LACTOSE INTOLERANCE; LACTOSE TOLERANCE; OUTCOME ASSESSMENT; PREVALENCE; RISK ASSESSMENT; SYSTEMATIC REVIEW; ULCERATIVE COLITIS; ETHNOLOGY; FACTUAL DATABASE; INFLAMMATORY BOWEL DISEASES; META ANALYSIS; METABOLISM; RISK FACTOR;

LACTASE; LACTOSE;

DAIRY PRODUCTS; DATABASES, FACTUAL; DIGESTION; HUMANS; INFLAMMATORY BOWEL DISEASES; LACTASE; LACTOSE; LACTOSE INTOLERANCE; PREVALENCE; RISK FACTORS;

EID: 84979774663     PISSN: None     EISSN: 14752891     Source Type: Journal    
DOI: 10.1186/s12937-016-0183-8     Document Type: Article

References (103)

1. Kostic AD, Xavier RJ, Gevers D. The microbiome in inflammatory bowel disease: Current status and the future ahead. Gastroenterol. 2014;146:1489-99.
2. Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA, et al. Linking long-term dietary patterns with gut microbial enterotypes. Sci. 2011;334:105-8.
3. Albenberg LG, Wu GD. Diet and the intestinal microbiome: associations, functions, and implications for health and disease. Gastroenterol. 2014;146:1564-72.
4. D'Souza S, Levy E, Mack D, Israel D, Lambrette P, Ghadirlan P, et al. Dietary patterns and risk for Crohn'sdisease in children. Inflamm Bowel Dis. 2008;14:367-73.
5. Ananthakrishnan AN, Khalili H, Song M, Higuchi LM, Richter JM, Nimptsch K, et al. High School Diet and Risk of Crohn's Disease and Ulcerative Colitis. Inflamm Bowel Dis. 2015;21:2311-9.
6. Dixon LJ, Kabi A, Nickerson KP, McDonald C. Combinatorial effects of diet and genetics on inflammatory bowel disease pathogenesis. Inflamm Bowel Dis. 2015;21:912-22.
7. Spooren CE, Pierik MJ, Zeegers MP, Feskens EJ, Masclee AA, Jonkers DM. Review article: the association of diet with onset and relapse in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2013;38:1172-87.
8. Shrier I, Szilagyi A, Correa JA. Impact of lactose containing foods and the genetics of lactase on diseases: An analytical review of population data. Nutr Cancer. 2008;60:292-300.
9. Szilagyi A, Leighton H, Burstein B, Xue X. Latitude, sunshine, and human lactase phenotype distributions may contribute to geographic patterns of modern disease: the inflammatory bowel disease model. Clin Epidemiol. 2014;6:183-98.
10. Mishkin S. Dairy sensitivity, lactose malabsorption, and elimination diets in inflammatory bowel disease. Am J Clin Nutr. 1997;65:564-7.
11. Savaiano DA, Boushey CJ, McCabe GP. Lactose intolerance symptoms assessed by meta-analysis: a grain of truth that leads to exaggeration. J Nutr. 2006;136:1107-13.
12. Matlik L, Savaiano D, McCabe G, VanLoan M, Blue CL, Boushey CJ. Perceived milk intolerance is related to bone mineral content in 10- to 13-year-old female adolescents. Pediatrics. 2007;120:e669-77.
13. Faure C, Giguere L. Functional gastrointestinal disorders and visceral hyprsensivity in children and adolescents suffering from Crohn's disease. Inflamm Bowel Dis. 2008;14:1569-74.
14. Vivinus-Nebot M, Frin-Mathy G, Bziouche H, Dainese R, Bernard G, Anty R, et al. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation. Gut. 2014;63:744-52.
15. Mishkin B, Yalovsky M, Mishkin S. Increased prevalence of lactose malabsorption in Crohn's disease patients at low risk for lactose malabsorption based ethnic origin. Am J Gastroenterol. 1997;92:1148-53.
16. Wells GA, Shea B, O'Connel D, Peterson J, Welch V, Losos M, et al. The Newcastle Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Available at: http://www.ohri.ca/programs/clinical-epidemiology/oxford.htm. Accessed 6th July 2016.
17. Moher D, Liberati A, Tetzlaff J. Altman DG, and the PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. Ann Intern Med. 2009;151:264-9.
18. Sweeting MJ, Sutton AJ, Lambert PC. What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. Stat Med. 2004;23:1351-75.
19. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta analyses. BMJ. 2003;327:557-60.
20. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719-48.
21. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-88.
22. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-34.
23. Pena AS, Truelove SC. Hypolactasia and ulcerative colitis. Gastroenterol. 1973;64:400-4004.
24. Eadala P, Matthews SB, Waud JP, Geen JT, Campbell AK. Association of lactose sensitivity with inflammatory bowel disease - demonstrated by analysis of genetic polymorphism, breath gases and symptoms. Aliment Pharmacol Ther. 2011;34:735-46.
25. Barrett JS, Irving PM, Shepherd SJ, Muir JG, Gibson PR. Comparison of the prevalence of fructose and lactose malabsorption across chronic intestinal disorders. Aliment Pharmacol Ther. 2009;30:165-74.
26. Von Tirpitz C, Kohn C, Steinkamp M, Geerling I, Maier V, Moller P, et al. Lactose intolerance in active Crohn's disease, Clinical value of duodenal lactase analysis. J Clin Gastroenterol. 2002;34:49-53.
27. Bernstein CN, Ament M, Artinian L, Ridgeway J, Shanahan F. Milk tolerance in adults with ulcerative colitis. Am J Gastroeneterol. 1994;89:872-7.
28. Park RH, Duncan A, Russell RI. Hypolactasia and Crohn's disease: a myth. Am J Gastroenterol. 1990;85:708-10.
29. Lobbley RW, Burrows PC, Warwick R, Dawson DJ, Holmes R. Simultaneous assessment of intestinal permeability and lactose tolerance with orally administered raffinose, lactose and L-arabinose. Clin Sci. 1990;79:175-83.
30. Kirschner BS, DeFavaro MV, Jensen W. Lactose malabsorption in children and adolescents with inflammatory bowel disease. Gastroenterol. 1981;81:829-32.
31. Tandon R, Mandell H, Spiro HM, Thayer WR. Lactose intolerance in Jewish patients with ulcerative colitis. Dig Dis. 1971;16:845-8.
32. Chalfin D, Holt PR. Lactase deficiency in ulcerative colitis, regional enteritis and viral hepatitis. Am J Dig Dis. 1967;12:81-7.
33. Gupta R, Makharia G, Khadgawat R, Yadav RK. Evaluation of lactose and milk intolerance and bone mineral density in Indian patients with inflammatory bowel disease. Natl Med J India. 2012;25:327-31.
34. Banos Madrid R, Salama Benerroch H, Moran Sanchez S, Gallardo Sanchez F, Albadalejo Merono A, La Mercader Martínez J. Lactose malabsorption in patients with inflammatory bowel disease without activity: would it be necessary to exclude lactose products in the diet of all patients. An Med Interna. 2004;21:212-4. Spa.
35. Ginard D, Riera J, Bonet L, Barranco L, Reyes J, Escarda A, et al. Lactose malabsorption in ulcerative colitis. A case - control study. Gastroenterol Hepatol. 2003;26:469-74. Spa.
36. Kochlar R, Mehta SK, Goenka MK, Mukherjee JJ, Rana SV, Gupta D. Lactose intolerance in idiopathic ulcerative colitis in north Indians. Indian J Med Res. 1993;98:79-82.
37. Pironi L, Callegari C, Ciornia GL, Lami F, Miglioti M, Barbara L. Lactose malabsorption in adult patients with Crohn's disease. Am J Gastroenterol. 1988;83:1267-71.
38. Ogata M, Yao T. Hypolactasia in Japanese Crohn's patients. Japn J Gastroenterol. 1992;89:2655-63. Jap.
39. Enattah NS, Kuokkanen M, Forsblom C, Natah S, Oksanen A, Jarvela I, et al. Correlation of intestinal disaccharidase activities with the C/T-13910 variant and age. World J Gastroenterol. 2007;13:3506-12.
40. Marton A, Xue X, Szilagyi A. Meta-analysis: The Diagnostic Accuracy of Lactose Breath Hydrogen or Lactose Tolerance Tests for Predicting the North European lactase polymorphism C/T - 13910.Alimentary. Pharmacol Ther. 2012;35:429-40.
41. Wiecke S, Wos H, Radziewicz-Winnick I, Komraus M, Gryzbowska-Chlebowczyk U. Disaccharidase activity in children with inflammatory bowel disease. Turk J Gastroenterol. 2014;25:185-91.
42. Huppe D, Tromm A, Langhorst H, May B. Lactose intolerance in chronic inflammatory bowel diseases. Dtsch Med Wochenschr. 1992;117:1550-5. Ger.
43. Cabrera - Acosta GA, Milke - Garcia MP, Ramirez - Iglesias MT, Uscanga L. Deficient lactose digestion and intolerance in a group of patients with chronic nonspecific ulcerative colitis: a controlled, double blind, cross-over clinical trial. Rev Gastroenterol Mex. 2012;77:26-30.
44. Gudmand-Hoyer E, Jarnum S. Incidence and clinical significance of lactose malabsorption in ulcerative colitis. Gut. 1970;11:338-43.
45. Busk HE, Dahlerup B, Lytzen T, Binder V, Gudmand-Hoyer E. The incidence of lactose malabsorption in ulcerative colitis. Scand J Gastroenterol. 1975;10:263-5.
46. Hessels J, Eidhof HHM, Steggink J, Roeloffzen WWH, Wu K, Tan G, et al. Assessment of hypolactasia and site - specific intestinal permeability by differential sugar absorption of raffinose, lactose, sucrose and mannitol. Clin Chem Lab Med. 2003;41:1056-63.
47. Dunne WT, Cooke WT, Allan RN. Enzymatic and morphometric evidence for Crohn's disease as a diffuse lesion of the gasrointestinal tract. Gut. 1977;18:290-4.
48. Newcomer AD, McGill DB. Incidence of lactase deficiency in ulcerative colitis. Gastroenterol. 1967;53:890-3.
49. Nolan-Clark D, Tapsell LC, Hu R, Han DY, Ferguson LR. Effects of dairy products on Crohn's disease symptoms are influenced by fat content and disease location but not lactose content or disease activity status in a New Zealand population. J Am Diet Assoc. 2011;1111:1165-72.
50. Kitahora T, Utsunomiya T, Yokota A. Epidemiological study of ulcerative colitis in Japan: incidence and familial occurrence. The Epidemiology Group of the Research Committee of Inflammatory Bowel Disease in Japan. J Gastroenterology. 1995;30 Suppl 8:5-8.
51. Shoda R, Matsueda K, Yamato S, Umeda N. Epidemiologic analysis of Crohn disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan. Am J Clin Nutr. 1996;63:741-5.
52. Magee EA, Edmond LM, Tasker SM, Kong SC, Curno R, John H Cummings JH. Associations between diet and disease activity in ulcerative colitis patients using a novel method of data analysis. Nutr J. 2005;4:7. doi: 10.1186/1475-2891-4-7.
53. Octoratou M, Merikas E, Malgarinos G, Stanciu C. Triantafillidis JKA prospective study of pre-illness diet in newly diagnosed patients with Crohn's disease. Rev Med Chir Soc Med Nat Iasi. 2012;116:40-9.
54. Abubakar I, Myhill DJ, Hart AR, Lake IR, Harvey I, Rhodes JM, et al. A case-control study of drinking water and dairy products in Crohn's Disease - further investigation of the possible role of Mycobacterium avium paratuberculosis. Am J Epidemiol. 2007;165:776-83.
55. Opstelten JL, Leenders M, Dik VK, Chan SS, van Schaik FD, Khaw KT, et al. Dairy Products, Dietary Calcium, and Risk of Inflammatory Bowel Disease: Results From a European Prospective Cohort Investigation. Inflamm Bowel Dis. 2016;22(6):1403-11.
56. Jowett SL, Seal CJ, Pearce MS, Phillips E, Gregory W, Barton JR, et al. Influence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort study. Gut. 2004;53:1479-84.
57. Jantchou P, Morois S, Clavel-Chapelon F, Boutron-Ruault MC, Carbonnel F. Animal protein intake and risk of inflammatory bowel disease: The E3N prospective study. Am J Gastroenterol. 2010;105:2195-201.
58. Reif S, Klein I, Lubin F, Farbstein M, Hallak A, Gilat T. Pre-illness dietary factors in inflammatory bowel disease. Gut. 1997;40(6):754-60.
59. Spehlmann ME, Begun AZ, Saroglou E, Hinrichs F, Tiemann U, Raedler A, et al. Risk factors in German twins with inflammatory bowel disease: results of a questionnaire-based survey. J Crohn's Colitis. 2012;6:29-42.
60. Joachim G. The relationship between habits of food consumption and reported reactions to food in people with inflammatory bowel disease - testing the limits. Nutr Health. 1999;13:69-83.
61. Jowett SL, Seal CJ, Phillips E, Gregory W, Barton JR, Welfare MR. Dietary beliefs of people with ulcerative colitis and their effect on relapse and nutrient intake. Clin Nutr. 2004;23:161-70.
62. Brasil Lopes M, Rocha R, Castro Lyra A, Rosa Oliveira V, Gomes Coqueiro F, Silveira Almeida N, et al. Restriction of dairy products; a reality in inflammatory bowel disease patients. Nutr Hosp. 2014;29:575-81.
63. Vernia P, Loizos P, Di Giuseppantonio I, Amore B, Chiappini A, Canizzaro S. Dietary calcium intake in patients with inflammatory bowel disease. J Crohn's Colitis. 2014;8:312-7.
64. Andresen AFR. Ulcerative colitis- an allergic phenomenon. Am J Dig Dis. 1942;9:91-8.
65. Binder JH, Gryboski JD, Thayer Jr WR, Spiro HM. Intolerance to milk in ulcerative colitis. A preliminary report. Am J Dig Dis. 1966;11:858-64.
66. Struthers Jr JE, Singleton JW, Kern Jr F. Intestinal lactase deficiency in ulcerative colitis and regional ileitis. Ann Intern Med. 1965;63:221-8.
67. Rana SV, Sharma S, Malik A, Kaur J, Prasad KK, Sinha SK, et al. Small intestinal bacterial overgrowth and orocecal transit time in patients with inflammatory bowel disease. Dig Dis Sci. 2013;58:2594-8.
68. Buning C, Ockenga JK, Krüger S, Jurga J, Baier P, Dignass A, et al. The C/C(-13910) and G/G9-22018) genotypes for adult-type hypolactasia are not associated with inflammatory bowel disease. Scand J Gastroenterol. 2003;38:538-42.
69. Elguezabal N, Chamorro S, Molina E, Garrido J, Izeta A, Rodrigo L, et al. Lactase persistence, NOD2 status and Mycobacterium avium subsp. Paratuberculosis infection associations to inflammatory bowel disease. Gut Pathogens. 2012;4:6.
70. Juste RA, Elguezabal N, Chamorro S, Molina E, Garrido JM, Riestra S, et al. Associations between CARD15 polymorphisms, MAPDNA in blood and lactase persistence in a Crohn's disease case-control study in north Spain, vol. 269. Minnesota: Proceedings of the 10th International Colloquim on Paratuberculosis; 2009. p. 9-14.
71. Nolan DJ, Han DY, Lam WJ, Morgan AR, Fraser AG, Tapsell LC, et al. Genetic adult lactase persistence is associated with risk of Crohn's disease in a New Zealand population. BMC Res Notes. 2010;3:339.
72. Murdoch TB, Bernstein CN, El-Gabalawy H, Stempak JM, Sargent M, Elias B, et al. Prevalence of genetic variants associated with inflammatory bowel disease in a healthy First Nations cohort. CMAJ. 2012;184:E435-441.
73. Gearry RB, Lea RA, Roberts RL, Chambers GK, Barclay ML, Kennedy MA. CARD 15 allele frequency differences in New Zealand Maori: ancestry specific susceptibility to Crohn's disease in New Zealand. Gut. 2006;55:580.
74. Yang J, Fox M, Cong Y, Chu H, Zheng X, Long Y, et al. Lactose intolerance in irritable bowel syndrome patients with diarrhoea: the roles of anxiety, activation of the innate mucosal immune system and visceral sensitivity. Aliment Pharmacol Ther. 2014;39:302-11.
75. Farup PG, Monsbakken KW, Vandvik PO. Lactose malabsorption in a population with irritable bowel syndrome: prevalence and symptoms. A case-control study. Scand J Gastroenterol. 2004;39:645-9.
76. Hertzler SR, Savaiano DA. Colonic adaptation to daily lactose feeding in lactose maldigesters reduces lactose intolerance. Am J Clin Nutr. 1996;64:232-6.
77. He T, Venema K, Priebe MG, Welling GW, Brummer RJ, Vonk RJ. The role of colonic metabolism in lactose intolerance. Eur J Clin Invest. 2008;38(8):541-7. doi: 10.1111/j.1365-2362.2008.01966.x.
78. Windey K, Houben E, Deroover L, Verbeke K. Contribution of Colonic Fermentation and Fecal Water Toxicity to the Pathophysiology of Lactose-Intolerance. Nutrients. 2015;7:7505-22. doi: 10.3390/nu7095349.
79. Szilagyi A, Rivard J, Shrier I. Diminished efficacy of colonic adaptation to lactulose occurs in patients with inflammatory bowel disease in remission. Dig Dis Sci. 2002;47:2811.
80. Gibson PR, Shepperd J. Personal view: food for thought - western lifestyle and susceptibility to Crohn's disease. The FODMAP hypothesis. Aliment Pharmacol Ther. 2005;21:1399-409.
81. Gearry RB, Irving PM, Barrett JS, Nathan DM, Shepherd SJ, Gibson PR. Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease-a pilot study. J Crohns Colitis. 2009;3:8-14.
82. Halpin SJ, Ford AC. Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol. 2012;107:1474-82.
83. Garg M, Gibson PR. Lactose intolerance in inflammatory bowel disease. Aliment Pharmacol Ther. 2011;34:1140-1.
84. Szilagyi A. Adaptation to Lactose in Lactase Non Persistent People: Effects on Intolerance and the Relationship between Dairy Food Consumption and Evaluation of Diseases. Nutrients. 2015;7:6751-79.
85. Szilagyi A, Nathwani U, Vinokuroff C, Correa JA, Shrier I. The effect of lactose maldigestion on the relationship between dairy food intake and colorectal cancer: a systematic review. Nutr Cancer. 2006;55:141-50.
86. Bueno-Hernández N, Núñez-Aldana M, Ascaño-Gutierrez I, Yamamoto-Furusho JK. Evaluation of diet pattern related to the symptoms of Mexican patients with Ulcerative Colitis (UC): through the validity of a questionnaire. Nutr J. 2015;14:25. doi: 10.1186/s12937-015-0014-3.
87. Suchy FJ, Brannon PM, Carpenter TO, Fernandez JR, Gilsanz V, Gould JB, et al. National institute of health consensus development conference: lactose intolerance in health. Ann Intern Med. 2010;152:792-6.
88. Lovegrove JA, Hobbs DA. Plenary Lecture 2: Milk and dairy produce and CVD: new perspectives on dairy and cardiovascular health. Proc Nutr Soc. 2016;24:1-12.
89. Abargouei AS, Janghorbani M, Salehi-Marzijarani M, Esmaillzadeh A. Effect of dairy consumption on weight and body composition in adults: a systematic review and meta-analysis of randomized controlled clinical trials. Int J Obesity. 2012;36:1485-93.
90. Lu L, Xun P, Wan Y, He K, Cai W. Long-term association between dairy consumption and risk of childhood obesity: a systematic review and meta-analysis of prospective cohort studies. Eur J Clin Nutr. 2016;70:414-23.
91. Aune D, Lau R, Chan DS, Vieira R, Greenwood DC, Kampman E, et al. Dairy products and colorectal cancer risk: A systematic review and meta-analysis of cohort studies. Ann Oncol. 2012;23:37-45.
92. Takayanagi H. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immun. 2007;7:292-304.
93. Ali T, Lam D, Bronze MS, Humphrey MB. Osteoporosis in inflammatory bowel disease. Am J Med. 2009;122:599-604.
94. Lima CA, Lyra AC, Rocha R, Santana GO. Risk factors for osteoporosis in inflammatory bowel disease patients. World J Gastrointest Pathophysiol. 2015;6:210-8.
95. Bernstein CN, Bector S, Leslie WD. Lack of relationship of calcium and vitamin D intake to bone mineral density in premenopausal women with inflammatory bowel disease. Am J Gastroenterol. 2003;98:2468-73.
96. Bernstein CN, Seeger LL, Anton PA, Artinian L, Geffrey S, Goodman W, et al. A randomized, placebo-controlled trial of calcium supplementation for decreased bone density in corticosteroid-using patients with inflammatory bowel disease: a pilot study. Aliment Pharmacol Ther. 1996;10:777-86.
97. Silvennoinen J, Lamberg-Allardt C, Kärkkäinen M, Niemelä S, Lehtola J. Dietary calcium intake and its relation to bone mineral density in patients with inflammatory bowel disease. J Intern Med. 1996;240:285-92.
98. Targownik LE, Bernstein CN, Nugent Z, Leslie WD. Inflammatory bowel disease has a small effect on bone mineral density and risk for osteoporosis. Clin Gastroenterol Hepatol. 2013;11:278-85.
99. Hartnett L, Egan LJ. Inflammation, DNA methylation and colitis-associated cancer. Carcinogenesis. 2012;33:723-31.
100. Cho E, Smith-Warner SA, Spiegelman D, Beson WL, van den Brandt PA, et al. Dairy foods, calcium and colorectal cancer: a pooled analysis of 10 cohort studies. J Nat Cancer Inst. 2004;96:1015-22.
101. Ananthakrishnan AN, Cheng SC, Cai T, Cagan A, Gainer VS, Szolovits P, et al. Association between reduced plasma 25-hydroxy vitamin D and increased risk of cancer in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2014;12:821-7.
102. Schepens MA, Schonewille AJ, Vink C, van Schothorst EM, Kramer E, Hendriks T, et al. Supplemental calcium attenuates the colitis-related increase in diarrhea, intestinal permeability, and extracellular matrix breakdown in HLA-B27 transgenic rats. J Nutr. 2009;139:1525-33.
103. Schicho R, Marsche G, Storr M. Cardiovascular complications in inflammatory bowel disease. Curr Drug Targets. 2015;16:181-8.